Lopez_2006_J.Mol.Neurosci_30_141

Reference

Title : Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement? - Lopez_2006_J.Mol.Neurosci_30_141
Author(s) : Lopez MG , Arias E , Sobrado M , Lorrio S , Roda JM , Garcia AG
Ref : Journal of Molecular Neuroscience , 30 :141 , 2006
Abstract :

The most frequent of the primary degenerative dementias is Alzheimer's disease (AD). The gradual loss of memory and attention in patients suffering from this illness are accompanied by aphasia, apraxia, agnosia, and alterations in visual-spatial perception. This group of symptoms is completed by emotional alterations, psychic instability, and changes in personality that appear in advanced phases of the illness. Different histopathological alterations have been described, like marked atrophy of the cerebral cortex with loss of cortical and subcortical neurons. Other histopathological hallmarks are the formation of senile plaques composed of beta-amyloid (Abeta) and neuro fibrillary tangles composed of hyperphosphorylation of tau protein.

PubMedSearch : Lopez_2006_J.Mol.Neurosci_30_141
PubMedID: 17192661

Related information

Citations formats

Lopez MG, Arias E, Sobrado M, Lorrio S, Roda JM, Garcia AG (2006)
Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement?
Journal of Molecular Neuroscience 30 :141

Lopez MG, Arias E, Sobrado M, Lorrio S, Roda JM, Garcia AG (2006)
Journal of Molecular Neuroscience 30 :141